251 related articles for article (PubMed ID: 31521684)
1. Neurohormonal Antagonists Are Preferred to an Implantable Cardioverter-Defibrillator in Preventing Sudden Death in Heart Failure.
Packer M
JACC Heart Fail; 2019 Oct; 7(10):902-906. PubMed ID: 31521684
[No Abstract] [Full Text] [Related]
2. ICDs Are Still an Effective Therapy to Prevent Sudden Cardiac Death in Heart Failure.
DeVore AD; Al-Khatib SM
JACC Heart Fail; 2019 Oct; 7(10):907-910. PubMed ID: 31521688
[No Abstract] [Full Text] [Related]
3. Waiting Period Before Implantable Cardioverter-Defibrillator Implantation in Newly Diagnosed Heart Failure With Reduced Ejection Fraction: A Window of Opportunity.
DeFilippis EM; Butler J; Vaduganathan M
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29138249
[No Abstract] [Full Text] [Related]
4. Prevention of sudden death in heart failure with reduced ejection fraction: do we still need an implantable cardioverter-defibrillator for primary prevention?
Abdelhamid M; Rosano G; Metra M; Adamopoulos S; Böhm M; Chioncel O; Filippatos G; Jankowska EA; Lopatin Y; Lund L; Milicic D; Moura B; Ben Gal T; Ristic A; Rakisheva A; Savarese G; Mullens W; Piepoli M; Bayes-Genis A; Thum T; Anker SD; Seferovic P; Coats AJS
Eur J Heart Fail; 2022 Sep; 24(9):1460-1466. PubMed ID: 35753058
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction: A Systematic Review and Network Meta-Analysis.
Tseng AS; Kunze KL; Lee JZ; Amin M; Neville MR; Almader-Douglas D; Killu AM; Madhavan M; Cha YM; Asirvatham SJ; Friedman PA; Gersh BJ; Mulpuru SK
Circ Arrhythm Electrophysiol; 2019 Jun; 12(6):e006951. PubMed ID: 31159582
[TBL] [Abstract][Full Text] [Related]
6. Compelling First-Line Drug and Device Therapies for the Prevention of Sudden Death in Patients With Chronic Heart Failure and a Reduced Ejection Fraction Who Are Candidates for an Implantable Cardioverter-Defibrillator.
Packer M
Circ Arrhythm Electrophysiol; 2019 Jun; 12(6):e007430. PubMed ID: 31159583
[No Abstract] [Full Text] [Related]
7. [Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure].
Mundhenke M
Dtsch Med Wochenschr; 2006 Oct; 131(41):2297-8; author reply 2298. PubMed ID: 17036279
[No Abstract] [Full Text] [Related]
8. [Heart failure].
Yonezawa M; Komuro I
Nihon Rinsho; 2002 Jul; 60(7):1422-6. PubMed ID: 12136624
[TBL] [Abstract][Full Text] [Related]
9. [Congestive heart failure and arrhythmia].
Kasanuki H
Nihon Rinsho; 1993 May; 51(5):1354-61. PubMed ID: 8101240
[TBL] [Abstract][Full Text] [Related]
10. Use of implantable cardioverter-defibrillators.
Aronow WS
Future Cardiol; 2010 Nov; 6(6):859-70. PubMed ID: 21142641
[TBL] [Abstract][Full Text] [Related]
11. Comments on the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.
Sionis A; ; Sionis Green A; Manito Lorite N; Bueno H; Coca Payeras A; Díaz Molina B; González Juanatey JR; Ruilope Urioste LM; Zamorano Gómez JL; ; Almenar Bonet L; Ariza Solé A; Bover Freire R; Lambert Rodríguez JL; López de Sá E; López Fernández S; Martín Asenjo R; Mirabet Pérez S; Pascual Figal D; Segovia Cubero J; Varela Román A; ; San Román Calvar JA; Alfonso Manterola F; Arribas Ynsaurriaga F; Evangelista Masip A; Ferreira González I; Jiménez Navarro M; Marin Ortuño F; Pérez de Isla L; Rodríguez Padial L; Sánchez Fernández PL; Sionis Green A; Vázquez García R
Rev Esp Cardiol (Engl Ed); 2016 Dec; 69(12):1119-1125. PubMed ID: 27894486
[No Abstract] [Full Text] [Related]
12. Sudden cardiac death in heart failure.
Klein L; Hsia H
Cardiol Clin; 2014 Feb; 32(1):135-44, ix. PubMed ID: 24286584
[TBL] [Abstract][Full Text] [Related]
13. Heart failure as a substrate and trigger for ventricular tachycardia.
Alvarez CK; Cronin E; Baker WL; Kluger J
J Interv Card Electrophysiol; 2019 Dec; 56(3):229-247. PubMed ID: 31598875
[TBL] [Abstract][Full Text] [Related]
14. Guideline-Directed Medical Therapy Before and After Primary Prevention Implantable Cardioverter Defibrillator Implantation in New Zealand (ANZACS-QI 66).
Foo FS; Lee M; Poppe KK; Clare GC; Stiles MK; Gavin A; Webber M; Jackson R; Kerr AJ
Heart Lung Circ; 2022 Nov; 31(11):1531-1538. PubMed ID: 35999128
[TBL] [Abstract][Full Text] [Related]
15. Lessons Learned and Insights Gained in the Design, Analysis, and Outcomes of the COMPANION Trial.
Bristow MR; Saxon LA; Feldman AM; Mei C; Anderson SA; DeMets DL
JACC Heart Fail; 2016 Jul; 4(7):521-535. PubMed ID: 27289408
[TBL] [Abstract][Full Text] [Related]
16. MY APPROACH to treating heart failure with reduced ejection fraction.
Greenberg BH
Trends Cardiovasc Med; 2014 Nov; 24(8):367-8. PubMed ID: 25267506
[No Abstract] [Full Text] [Related]
17. A risk score to predict the absence of left ventricular reverse remodeling: Implications for the timing of ICD implantation in primary prevention.
Pérez-Rodon J; Galve E; Pérez-Bocanegra C; Soriano-Sánchez T; Recio-Iglesias J; Domingo-Baldrich E; Alzola-Guevara M; Ferreira-González I; Marsal JR; Ribera-Solé A; Gutierrez García-Moreno L; Cruz-Carlos LM; Rivas-Gandara N; Roca-Luque I; Francisco-Pascual J; Evangelista-Masip A; Moya-Mitjans À; García-Dorado D
J Cardiol; 2018 May; 71(5):505-512. PubMed ID: 29183646
[TBL] [Abstract][Full Text] [Related]
18. Primary prevention of sudden cardiac death in heart failure: will the solution be shocking?
Uretsky BF; Sheahan RG
J Am Coll Cardiol; 1997 Dec; 30(7):1589-97. PubMed ID: 9385881
[TBL] [Abstract][Full Text] [Related]
19. Implantable cardioverter-defibrillators.
Kukin ML
N Engl J Med; 2009 Feb; 360(9):937; author reply 937-8. PubMed ID: 19246371
[No Abstract] [Full Text] [Related]
20. Implantable cardioverter-defibrillators.
Aronow WS
Am J Ther; 2010; 17(6):e208-20. PubMed ID: 19918166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
